On November 19–20, 2025 the annual meeting of the OMCL network concerning Centrally Authorised Products (CAP) took place in Brussels. The event was hosted by Sciensano – the Belgian research institute and national public health institute, whose activities focus on public health, animal health, and food safety.

The Head of the Quality Control Department for Veterinary Medicinal Products at the State Research Institute for Veterinary Medicine, Ms. Ewa Borzym, M.Sc. Eng., participated in the meeting, which constitutes a key element of European monitoring of medicinal products registered through the centralized procedure. This system enables effective pharmaceutical supervision and ensures the safety of products authorized for marketing throughout the EU by the European Medicines Agency (EMA).

During this year’s meeting, the following topics were discussed:
– results of completed monitoring programs,
– the testing plan for 2026,
– results of compliance assessments of packaging and package leaflets with approved templates,
– updated EDQM guidelines concerning CAP testing,
– laboratory experience in testing parameters specified in medicinal product specifications.

National Veterinary Institute actively participates in annual monitoring programs and also has its representative in the CAP Advisory Group, supporting the development and coordination of European supervision over the quality of medicinal products.